Article
Mitosis may be an obligatory route to terminal differentiation in the Friend erythroleukemia cell.
Experimental cell research - 1 Nov 1990
Dinnen R, Ebisuzaki K
Abstract excerpt
In previous studies, it was shown that treatment of Friend erythroleukemia (FEL) cells with dimethylsulfoxide (DMSO) and the poly(ADP-ribose) polymerase inhibitor 3-aminobenzamide (3AB) blocked the differentiation pathway just prior to commitment. These studies show that the exposure of DMSO(+3AB)-induced cells to the mitotic inhibitors colcemid or nocodazole resulted in commitment to terminal differentiation....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
